Person: ERENBERK, UFUK
9 results
Search Results
Now showing 1 - 9 of 9
Publication Metadata only Short-term efficacy of ORS formulation and propranolol regimen in children with POTS(2020-08-01T00:00:00Z) YOZGAT, Yılmaz; OTÇU TEMUR, Hafize; Coban, Senay; Oner, Taliha; Karaarslan, Utku; Yozgat, Can Yilmaz; Karadeniz, Cem; ERGÖR, Serap Nur; ERENBERK, UFUK; YOZGAT, YILMAZ; OTÇU TEMUR, HAFİZE; ERGÖR, SERAP NUR; ERENBERK, UFUKBackground: To evaluate the short-term effectiveness of reduced-osmolarity oral rehydration salt formulation (ORS) and propranolol in children diagnosed with postural orthostatic tachycardia syndrome (POTS) in head-up tilt testing (HUTT).Publication Metadata only Human Paraoxonase-1 Activity in Children with Acute Bronchiolitis(2020-03-01) ERENBERK U.; USTABAŞ KAHRAMAN F.; ÖZKAYA E.; NURSOY M. A.; DOĞAN DEMİR A.; TÜREL Ö.; ERENBERK, UFUK; USTABAŞ KAHRAMAN, FEYZA; NURSOY, MUSTAFA ATİLLA; DOĞAN DEMİR, AYŞEGÜL; TÜREL, ÖZDENINTRODUCTION: Human paraoxonase-1 (PON1) is one of the endogenous antioxidant molecules working against oxidative stress. We aimed to investigate serum PON1 activity in children with acute bronchiolitis.Publication Metadata only Bewertung der Funktionen des rechten Herzens bei Kindern mit leichter Mukoviszidose.(2021-02-18T00:00:00Z) Guliyeva, Aynur; Cakir, Erkan; Yazan, Hakan; AlShadfan, Lina; Sharifov, Rasul; Temur, Hafize Otcu; Karaarslan, Utku; Yozgat, Can Yilmaz; Yakut, Kahraman; Yozgat, YILMAZ; ÇAKIR, ERKAN; ERENBERK, UFUK; YOZGAT, YILMAZPublication Metadata only A Snapshot of Pediatric Patients with COVID-19 in a Pandemic Hospital(2020-10-01T00:00:00Z) BURSAL DURAMAZ, BURCU; TÜREL, Özden; KORKMAZ, ÇİĞDEM; KARADOĞAN, MUHAMMED TALHA; Yozgat, Can Yilmaz; İŞCAN, AKIN; SÜMBÜL, BİLGE; ERENBERK, UFUK; BURSAL DURAMAZ, BURCU; TÜREL, ÖZDEN; KORKMAZ, ÇİĞDEM; KARADOĞAN, MUHAMMED TALHA; İŞCAN, AKIN; SÜMBÜL, BİLGE; ERENBERK, UFUKAim Reports describing coronavirus disease 2019 (Covid-19) in children are fewer than adult studies due to milder clinical picture. We aimed to share our experience at a single center with an emphasis on collective decision making.Publication Metadata only Human paraoxonase-1 activity in children with acute bronchiolitis Akut bronşiolitli çocuklarda human paraoksonaz-1 aktivitesi(2020-01-01T00:00:00Z) ERENBERK, UFUK; Kahraman, Feyza Ustabaş; Özkaya, Emin; NURSOY, MUSTAFA ATİLLA; Demir, Ayşegül Doğan; TÜREL, Özden; ERENBERK, UFUK; ÖZKAYA, EMİN; NURSOY, MUSTAFA ATİLLA; TÜREL, ÖZDEN© 2020, Galenos. All rights reserved.INTRODUCTION: Human paraoxonase-1 (PON1) is one of the endogenous antioxidant molecules working against oxidative stress. We aimed to investigate serum PON1 activity in children with acute bronchiolitis. MATERIALS and METHODS: A total of 29 children aged between 3-21 months with acute bronchiolitis and 35 age-matched healthy controls were included in the study. Bronchiolitis patients were further classified as mild (65%) and moderate (35%). Paraoxonase and arylesterase activities of PON1 were compared between patients with acute bronchiolitis and the control group. RESULTS: Paraoxonase activity of children with acute bronchiolitis was lower than healthy controls but the difference was not significant (127.53 ± 64.17 U/L versus 153.95 ± 74.40 U/L) (p=0.13). Arylesterase activity was significantly decreased in children with mild and moderate bronchiolitis in comparison to the control group (142.43± 56.60 kU/L and 103.70± 26.03 kU/L versus 201.09± 57.26 kU/L) (p<0.001). CONCLUSIONS: Serum PON1 activity was lower in children with acute bronchiolitis compared to controls. Increasing antioxidant capacity may be an effective means of therapy in viral induced lung disease.Publication Metadata only Kardiyak Rabdomiyomu Olmayan Tuberous SklerozluHastalarda Kardiyak Aritmilerin ElektrokardiyografikBelirteçlerle Değerlendirilmesi(2020-03-02T00:00:00Z) YOZGAT, YILMAZ; KUŞ, HAZAR DOĞUŞ; Yozgat, Can Yılmaz; USTABAŞ KAHRAMAN, FEYZA; Yüksel, Mine; YAKUT, KAHRAMAN; İşçan, Akın; ERENBERK, UFUK; YOZGAT, YILMAZ; KUŞ, HAZAR DOĞUŞ; USTABAŞ KAHRAMAN, FEYZA; YAKUT, KAHRAMAN; ERENBERK, UFUKPublication Open Access Dermatological Manifestation of Pediatrics Multisystem Inflammatory Syndrome Associated with COVID-19 in a 3-Year-Old Girl.(2020-06-04T00:00:00Z) Yozgat, CY; Uzuner, S; Duramaz, BB; Yozgat, Yılmaz; Erenberk, U; Iscan, A; Turel, O; UZUNER, SELÇUK; YOZGAT, YILMAZ; ERENBERK, UFUK; TÜREL, ÖZDENPublication Open Access Evaluation of diagnostic components and management of childhood pulmonary tuberculosis: a prospective study from Istanbul, Turkey.(2022-01-31T00:00:00Z) Dogan Demir, Aysegul; Kut, Arif; Ozaydin, Erhan; Cakir, Fatma Betul; Nursoy, Mustafa; Ustabas Kahraman, Feyza; Erenberk, Ufuk; Uzuner, Selcuk; Collak, Abdulhamit; Cakin, Zeynep Ebru; Cakir, Erkan; ÇAKIR, FATMA BETÜL; USTABAŞ KAHRAMAN, FEYZA; ERENBERK, UFUK; UZUNER, SELÇUK; ÇAKIR, ERKANIntroduction: The diagnosis of childhood tuberculosis is difficult and most of the patients are diagnosed clinically. The objective of this study is to reveal the diagnostic and therapeutic components of childhood pulmonary tuberculosis and to analyze the changes that occurred in our country over the years. Methodology: All patients diagnosed with tuberculosis between 2006 and 2016 were included. Demographic characteristics, diagnostic and treatment outcomes were recorded and patients were followed up prospectively. Results: A total of 492 patients were included in the study. 97% had Bacillus Calmette-Guerin vaccine, 36% were diagnosed with microbiologically-confirmed tuberculosis and 64% were diagnosed with clinically-proven tuberculosis. 94% of the patients had symptoms consistent with tuberculosis, all patients had radiologic findings, 74% had a history of tuberculosis contact and 63% had tuberculin skin test positivity. The diagnoses included primary tuberculosis in 62%, secondary tuberculosis in 21%, progressive primary tuberculosis in 13% and miliary tuberculosis in 4%. 48% of the patients received a treatment regimen containing three drugs as the initial treatment, and drug-related side effects developed in 12%. Isoniazid resistance was detected in 13% of the patients and rifampicin resistance was detected in 8%. None of the patients died due to tuberculosis. In the last 50 years in Turkey, the rates of Bacillus Calmette-Guerin vaccination and diagnosis of tuberculosis cases have increased and the mortality rates have decreased over the years. Conclusions: Our study is one of the few prospective studies and revealed the differences between the recent data and the past 50 years in childhood tuberculosis in Turkey.Publication Metadata only The Success of the Cystic Fibrosis Registry of Turkey for Improvement of Patient Care.(2022-01-31T00:00:00Z) Erenberk, Ufuk; Sismanlar Eyuboglu, Tugba; Aslan, Ayse Tana; Gursoy, Tugba Ramasli; Emiralioglu, Nagehan; Yalcin, Ebru; Kiper, Nural; Sen, Velat; Sen, Hadice Selimoglu; Altintas, Derya Ufuk; Ozcan, Dilek; Kilinc, Ayse Ayzit; Cokugras, Haluk; Baskan, Azer Kilic; Yazan, Hakan; Unal, Gökcen; Yilmaz, Aslı Imran; Keskin, Ozlem; Arik, Elif; Kucukosmanoglu, Ercan; Irmak, Ilim; Damadoglu, Ebru; Ozturk, Gökcen Kartal; Gulen, Figen; Basaran, Abdurrahman Erdem; Bingol, Aysen; Cekic, Sukru; Sapan, Nihat; Kilic, Gonca; Harmanci, Koray; Kose, Mehmet; Ozdemir, Ali; Tugcu, Gokcen Dilsa; Polat, Sanem Eryilmaz; Hangul, Melih; Ozcan, Gizem; Aydin, Zeynep Gokce Gayretli; Yuksel, Hasan; Topal, Erdem; Ozdogan, Sebnem; Caltepe, Gonul; Suleyman, Ayse; Can, Demet; Ekren, Pervin Korkmaz; Bal, Cem Murat; Kilic, Mehmet; Cinel, Guzin; Cobanoglu, Nazan; Pekcan, Sevgi; Cakir, Erkan; Ozcelik, Ugur; Prof, Deniz Dogru; ERENBERK, UFUK; DOĞAN, GÜZİDE; ÇAKIR, ERKAN